We are live on ! Find out more
ABG

Ally Bridge Group Portfolio holdings

AUM $124M
1-Year Est. Return 249.88%
This Fund
S&P 500
This Quarter Est. Return
+50.35%
1 Year Est. Return
+249.88%
3 Year Est. Return
+942.29%
5 Year Est. Return
+671.08%
10 Year Est. Return
–
AUM
$164M
AUM Growth
+$44M
Cap. Flow
+$36.1M
Cap. Flow %
21.98%
Top 10 Hldgs %
70.97%
Holding
38
New
14
Increased
3
Reduced
6
Closed
14

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$12.2M
2
ASND icon
Ascendis Pharma A/S
ASND
+$9.53M
3
ATAI icon
AtaiBeckley Inc
ATAI
+$9.29M
4
SLNO
Soleno Therapeutics
SLNO
+$9.17M
5
TSHA icon
Taysha Gene Therapies
TSHA
+$5.37M

Top Sells

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.2M
2
MRUS
Merus
MRUS
+$7.37M
3
LENZ
LENZ Therapeutics
LENZ
+$6.18M
4
ELVN icon
Enliven Therapeutics
ELVN
+$5.64M
5
ORIC icon
Oric Pharmaceuticals
ORIC
+$4.93M

Sector Composition

Rank Sector Weight
1 Healthcare 72.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELVN icon
26
Enliven Therapeutics
ELVN
$3.78B
– –
-281,394
Closed -$5.64M
GERN icon
27
Geron
GERN
$911M
– –
-3,251,475
Closed -$4.58M
INSM icon
28
Insmed
INSM
$23.2B
– –
-47,710
Closed -$4.8M
KRRO icon
29
Korro Bio
KRRO
$153M
– –
-154,223
Closed -$1.93M
LXEO icon
30
Lexeo Therapeutics
LXEO
$366M
– –
-867,302
Closed -$3.49M
MRUS
31
DELISTED
Merus
MRUS
– –
-140,208
Closed -$7.37M
ORIC icon
32
Oric Pharmaceuticals
ORIC
$1.25B
– –
-485,629
Closed -$4.93M
PRAX icon
33
Praxis Precision Medicines
PRAX
$9.07B
– –
-80,880
Closed -$3.92M
RARE icon
34
CALL
Ultragenyx Pharmaceutical
RARE
$2.65B
– –
-1,600
Closed -$5.82M
REPL icon
35
Replimune Group
REPL
$814M
– –
-528,491
Closed -$3.38M
RNAM
36
DELISTED
Avidity Biosciences
RNAM
– –
-132,744
Closed -$3.77M
VRNA
37
DELISTED
Verona Pharma
VRNA
– –
-160,701
Closed -$15.2M
ATYR
38
aTyr Pharma
ATYR
$46.4M
– –
-287,720
Closed -$1.3M
1
2

Similar funds

MP
Marcho Partners London, United Kingdom $124M AUM 15.03% 1-Year Est. Return
EWP
E-Wealth Partners Minnetonka, Minnesota $124M AUM
WFA
WJ Financial Advisors Killingworth, Connecticut $124M AUM
VWM
Vigil Wealth Management Ponte Vedra Beach, Florida $124M AUM
EI
EDMP Inc Lutz, Florida $124M AUM 19.53% 1-Year Est. Return
TC
Town Capital Bel Air, Maryland $124M AUM
IFO
Intrepid Family Office Sarasota, Florida $124M AUM 37.91% 1-Year Est. Return
CRW
Clarity Retirement & Wealth New Bedford, Massachusetts $124M AUM

Ally Bridge Group's Q3 2025 Portfolio in Review

As of Q3 2025, Ally Bridge Group held 38 positions worth $164M, up 37% from $120M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Ally Bridge Group deployed $36.1M of net new capital in Q3 2025, opening 14 new positions and adding to 3 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 32,662 shares worth $15M.

By sector, the portfolio is most concentrated in Healthcare at 73% of assets, down from 95% a quarter earlier.

On the sell side, the largest reduction was LENZ Therapeutics, an estimated $6.18M trimmed.

  • Ally Bridge Group's largest Q3 2025 buy was Madrigal Pharmaceuticals: 32,662 shares worth $15M.
  • Ally Bridge Group added most to Soleno Therapeutics in Q3 2025, an estimated $9.17M increase.
  • Ally Bridge Group's biggest Q3 2025 reduction was LENZ Therapeutics, cutting an estimated $6.18M.
  • Ally Bridge Group fully exited Verona Pharma in Q3 2025, selling an estimated $15.2M.
  • Ally Bridge Group's ten largest holdings make up 71% of its $164M portfolio in Q3 2025.
  • Ally Bridge Group opened 14 new positions and closed 14 in Q3 2025.
  • Ally Bridge Group's portfolio value rose 37% quarter-over-quarter to $164M.

Based on Ally Bridge Group's 13F filing for Q3 2025, filed 14 Nov 2025.